Research and Development

Amgen has announced that its multiple myeloma therapy Kyprolis displayed superiority to Takeda’s Velcade in the Phase III ENDEAVOR study …

Two weeks after its $160 billion buyout of botox-maker Allergan, Pfizer has announced that it is to close a UK …

Alzheimer’s Research UK has appointed three chief scientific officers to drive its £30million Drug Discovery Alliance. The Alliance, which unites …

“We think we can be the next Biogen, or a Celgene or a Vertex – we have that much firepower …

NICE has published draft guidance as part of its highly specialised technologies programme, not recommending Alexion Pharma’s Strensiq (asfotase alfa) …

GSK has entered the ‘smart drug’ industry by partnering with a health technology company to develop a sensor for use …

GlaxoSmithKline has received marketing authorisation from the European Commission for Nucala as an add-on treatment for severe refractory eosinophilic asthma …

Janssen has announced a new collaboration with the non-profit organisation FIND to step-up the fight against the public health threat …

Zafgen has announced the death of a second participant in a Phase III clinical trial of its obesity drug beloranib …

Novo Nordisk has announced its purchase of a type 2 diabetes diabetes program in a deal with biotech firm Xoma …

The European Commission has approved Ravicti for rare urea cycle disorders.  Ravicti, (glycerol phenylbutyrate), is an oral liquid developed by Horizon …

UK drugs regulator NICE has published updated guidelines on type 2 diabetes, saying that taking an individualised approach to care …

Pfizer UK has received European Commission approval for a label update to expand use of Xalkori (crizotinib) to first-line treatment …

Johnson &Johnson is entering four new public-private partnerships aimed at significantly reducing the burden of HIV incidence among young girls …

PureTech Health has compiled a scientific advisory board of distinguished scientists and physicians to expand its senior team.  The scientific …